The FDA has authorized urcosimod 0.05% for single-patient expanded access, or compassionate use, in a patient with ...
AI has the potential to transform cataract surgery outcomes for the better, according to a speaker. Surgical planning, predictive analytics for patient recovery and postoperative assessments are a few ...
From artificial intelligence and IOL innovation to biosimilars, geographic atrophy, and postoperative eye protection, Joshua ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results